Exploring the Collaborative Care Approach for Students with Type 1 Diabetes

Impact of the Collaborative Care Model on Quality of Life and Self-Efficacy Among Students with Type 1 Diabetes: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241130063895N1

Enrollment

Registered

2025-01-08

Start date

2024-12-21

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes. Type 1 diabetes mellitus

Interventions

Intervention 1: Intervention group: The participatory care model is implemented with researcher management for the intervention group. The participatory care model in this study consists of four stage

Eligibility

Sex/Gender

All

Age

12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Participants must be between 12 and 18 years old at the time of enrollment. Participants must be currently enrolled as students in a primary or secondary school. Participants must have a caregiver involved in their care and support. The student and their caregiver must be mentally healthy and free from significant mental illnesses. Participants must have a confirmed diagnosis of Type 1 diabetes made by a pediatrician. Participants must have a confirmed diagnosis of Type 1 diabetes made by a pediatrician. Participants must provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Individuals who do not meet the inclusion criteria will be excluded. Individuals with any other chronic illness will be excluded. If either the child or the caregiver develops a mental illness during the study, they will be excluded.

Design outcomes

Primary

Measure	Time frame
Quality of Life Questionnaire Score (DQOLY). Timepoint: Measurement of quality of life score at the beginning of the study (before the intervention) and at the end of the fifth intervention session (sixth session). Method of measurement: Type 1 Diabetic Adolescent Quality of Life Questionnaire (DQOLY).;Self-efficacy questionnaire for diabetic patients. Timepoint: Measuring self-efficacy scores at the beginning of the study (before the intervention) and at the end of the fifth intervention session (sixth session). Method of measurement: Self-efficacy questionnaire for diabetic patients.	—

Measure

Time frame

Quality of Life Questionnaire Score (DQOLY). Timepoint: Measurement of quality of life score at the beginning of the study (before the intervention) and at the end of the fifth intervention session (sixth session). Method of measurement: Type 1 Diabetic Adolescent Quality of Life Questionnaire (DQOLY).;Self-efficacy questionnaire for diabetic patients. Timepoint: Measuring self-efficacy scores at the beginning of the study (before the intervention) and at the end of the fifth intervention session (sixth session). Method of measurement: Self-efficacy questionnaire for diabetic patients.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimin Aghaee

Yasouj University of Medical Sciences

siminaghaee97@gmail.com+98 61 4242 9752

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026